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INTRODUCTION 
Copy number variants (CNVs) are stretches of DNA with a deletion or duplication.1 They are important 
contributors to mental illness and affect cognition in the general population.2–4 CNVs at the 16p11.2 locus 
(600 kb BP4-BP5 breakpoints; 29.6–30.2 Mb; GRCh37/hg19) have been associated with neurodevelopmental 
and psychiatric disorders. Although the duplication has been associated with autism spectrum disorder and 
schizophrenia,5,6 carrying the deletion is a risk factor for autism spectrum disorder.6–8 We and others also 
demonstrated that the number of genomic copies at this locus correlates with body mass index (BMI) and 
brain volume.5,9–14 Speciﬁcally, while deletion carriers present a 43-fold increased risk of morbid obesity, 
duplication carriers have an eightfold risk of being underweight.12–14 Murine models engineered to carry 
deletions and duplications that are paralogous to the 16p11.2 rearrangements show BMI phenotypes that are 
inverse to those observed in human, with deletion and duplication mice being under- and overweight, 
respectively.15,16 
Obesity has been associated with cognitive as well as reward dysfunction in the literature.17 Numerous 
studies have investi-gated the relationship between cognition, behavior and BMI.18 More speciﬁcally, deﬁcits 
in inhibition and decision making have been associated with higher BMI in both children and adults.19–22 
Study of these reciprocal CNVs with large effects is a unique opportunity to investigate high-risk individuals 
before and after the onset of obesity, as well as the relationships with cognitive and behavioral comorbidities. 
Recent studies suggest that diminished response to satiety is a strong contributor mediating genetic forms of 
obesity in childhood.23–26 To date, only one study27 reported eating behavior in 16p11.2 deletion carriers. 
Using a parental report questionnaire investigating aspects of disinhibited eating, the authors found that the 
deletion was associated with eating in the absence of hunger and that this association was primarily driven by 
two factors: sensitivity to external cues and boredom. Interestingly, these ﬁndings were independent of 
parental feeding practices. 
In this study, we hypothesize that the deletion is associated with altered eating behavior and that cognitive 
deﬁcits (in particular, executive dysfunctions) are associated with more extreme BMI. We therefore aimed at: 
(1) assessing eating behavior through self- and parent report in deletion and duplication carriers, as compared 
with controls, (2) comparing deletion carriers with individuals presenting with obesity or binge eating/loss of 
control disorder or bulimia and (3) investigating the relationship between BMI and cognition. 
SUBJECTS AND METHODS 
Subjects 
The study was reviewed and approved by the local Ethics committee of each site conducting the study. 
Informed written consents were obtained from participants or legal caregivers before inclusion in the study. 
Clinical characteristics of the adult and pediatric samples are presented in  Table 1. Pediatric samples. We 
collected data on 73 deletion carriers (59 families), 42 controls (18 intrafamilial and 24 extrafamilial) and 39 
duplication carriers (31 families) ascertained through two different cohorts: 16p11.2 European Consortium and 
the Experiences of Children with Copy Number Variants (ECHO) study in Cardiff, United Kingdom 
(Supplementary Table 1). 
Participants from the 16p11.2 European Consortium were taking part in a larger phenotyping project on the 
deletion/duplication of the 16p11.2 region. Most carriers were referred to the study by the clinical geneticist 
who had initially established the genetic diagnosis (whole-genome arrays) in the context of a 
neurodevelopmental disorder. The inclusion criteria include the presence of a 16p11.2 deletion or duplication 
comprising the BP4-BP5 region (29.6–30.2—according to the human genome build GRCh37/hg19). Intrafamilial 
controls were non-carriers sibling from the same family. Extrafamilial controls were recruited in the general 
popula-tion. Intra- and extrafamilal controls have a BMI z-score between − 2.5 and 2.5 s.d. Given the absence 
of signiﬁcant differences between intrafamilial and extrafamilial controls, we merged both samples into a 
single control group for statistical analyses (Supplementary Table 1). The exclusion criteria include none beside 
age o3 years. 
Data were also available from the ECHO study, which recruited through medical genetics clinics across the 
United Kingdom, various charities, word of mouth and the ECHO study website 
(http://medicine.cardiff.ac.uk/psychological-medicine-neuroscience/areas-research/copy-number-variant-
research/research-projects/). The presence of the 16p11.2 CNV was conﬁrmed from medical records and/or by 
the laboratory of the Institute of Psychological Medicine and Clinical Neurosciences at the Cardiff University. 
Intrafamilial controls were non-carrier siblings closest in age to the child with the CNV (one invited per family). 
To examine the speciﬁcity of eating behavior in CNV carriers, we compared results with a group of 26 children 
who met the criteria for loss of control over eating according to the diagnosis criteria adapted for children.28 
All children participated in a research project (Swiss University Study of Nutrition, SUN) at the Fribourg 
University, Switzerland. Detailed description of the study and recruitment methods can be found in Kurz et 
al.29 Children with loss of control over eating were older than deletion carriers (P=0.005), but there were no 
difference in gender or BMI z-score (Supplementary Table 2). 
 
Adult samples. We examined a total of 25 adult deletion carriers (21 families), 28 duplication carriers (21 
families) and 38 intrafamilial controls (spouse of carriers from 26 families) from the 16p11.2 European 
Consortium (Table 1). Inclusion and exclusion criteria were the same as the ones used for the pediatric sample. 
To examine the speciﬁcity of eating behavior in CNV carriers, we compared results to a group with obesity (OB, 
N=232), a group with diagnosis of binge eating disorder (BED, N= 154) and a group with bulimia nervosa (BN, 
N=274). They were diagnosed by experienced psychologists and psychiatrists according to the DSM-5 
criteria.30 The three cohorts were recruited from the Eating Disorder Unit in the Department of Psychiatry at 
the University Hospital of Bellvitge, Barcelona, Spain. 
Deletion carriers were younger than the OB group but did notdifferfromthetwootherclinical groups (BN and 
BED). There was no difference in education level. Deletion carriers had a higher BMI z-score compared with 
the BN cohort but they did not signiﬁcantly differ from the OB or BED groups. Finally, there was a balanced 
gender distribution in the deletion group, whereas there were considerably more females in the two clinical 
and obese groups (Supplementary Table 3). 
 
Anthropometric measures 
BMI z-scores were computed for all data using a gender, age and geographically matched reference population 
as previously described in Zufferey et al.14 
Neuropsychological measures 
Overall cognitive functioning was measured using either the Wechsler Intelligence Scales for Children (WISC-
IV)31 or the Wechsler Intelligence Scale for Adults (WAIS-III)32 with participants assessed in Lausanne. The 
Wechsler Abbreviated Scale of Intelligence (WASI)33 was used with participants from the ECHO study. We 
used the Full Scale Intellectual Quotient (FSIQ) as outcome measure. Verbal inhibition skills were assessed 
with the Stroop test34 (⩾ age 8 years) and motor inhibition with a computerized version of the Go-Nogo 
task35 ( ⩾ age 7 years). Raw score for error numbers was used as outcome measure in both tasks. 
 
 
 
Eating behavior assessment 
Pediatric cohort. Parent report was used to assess food-related behaviour in children or young adults ( ⩽20 
years) unable to complete self-report because of low cognitive level. 
Child Eating Behavior Questionnaire (CEBQ, age ⩾ 3):36 This parent report instrument (35 items) includes four 
subscales related to children’s food approach behaviors—Food Responsiveness, Emotional Over Eating, 
Enjoyment of Food and Desire to Drink—and four subscales assessing avoidant-type responses—Satiety 
Responsiveness, Slowness in Eating, Emotional Under Eating and Food Fussiness. Response to each question is 
given on a 5-point Likert scale (1 = never to 5 = always). We used the mean raw score on each subscale as the 
outcome measure. 
Adult cohort. Data on eating behavior were acquired through self-reports on the following measures: 
Eating Disorder Inventory-2 referral form (⩾ age 12 years):37 This questionnaire is a self-report measure to 
assess symptomatology of eating problems (three subscales) and more general psychological difﬁculties (ﬁve 
subscales). In this study, we only used the subscales related to eating problems: Drive for Thinness, Bulimia 
and Body Dissatisfaction. Responses are given using a 6-point Likert scale (1 = never to 6 = always). We used 
total raw scores of each subscale as the outcome measure. 
Dutch Eating Behavior Questionnaire—Externality subscale ( ⩾ age 10 years):38 This 10-item subscale assesses 
whether participants are attracted to food stimuli and tend to eat regardless of the internal state of hunger or 
satiety. Each item consists of a 5-point Likert scale (1 = never to 5 = very often). We used the mean raw score 
as outcome measure. 
Statistical analyses 
Effect of CNVs on eating behavior traits. To estimate the effect of the 16p11.2 on eating behavior, we 
conducted linear mixed models to compare eating disorder behavior in the deletion versus control, deletion 
versus duplication and duplication versus control, whereas accounting for correlated measures within families 
(familial clustering). We systematically controlled for age, gender and FSIQ (Supplementary Tables 4 and 5), 
and only signiﬁcant covariates were included in the ﬁnal statistical model. Linear regression model was used to 
compare deletion carriers with clinical groups (obesity, BN and BED), while controlling for age, gender and 
education level (Supplementary Table 6). Given the high collinearity between BMI z-score and the number of 
genomic copies, we subsequently added BMI z-score as an explanatory variable. Finally, we assessed the 
inheritance factor on eating behavior by introducing inheritance in the statistical model as a covariate (de novo 
or inherited from a parent). 
Relationship between BMI, eating behavior scores and cognition within CNV groups. Pearson's correlation 
analyses explored the relationship between BMI and cognition (FSIQ, executive functions), as well as BMI and 
eating behavioral traits within a group. We used similar analysis to assess the correlation between FSIQ and 
eating behavior scores. Bonferroni-corrected P-values were obtained by multiplying the original P-values by 
the number of possible comparisons (n= 3): P-values ⩽0.016 were considered signiﬁcant in the pediatric and 
adult cohorts when comparing CNVs carriers with controls, whereas P-values ⩽ 0.0083 were considered 
signiﬁcant when comparing adult deletion carriers with the clinical and obese groups (n=6 comparisons). 
Owing to missing data, the sample size might differ between outcome measures. Statistical analyses were 
conducted using IBM SPSS (version 21.0, released 2012; IBM Corp., SPSS Statistics for Windows, Armonk, NY, 
USA) and R 3.1.1 (The R Project for Statistical Computing; http://www.R-project.org/). 
 
RESULTS 
Children: Eating behavior differences between CNV carriers and controls 
CEBQ scores are described in Supplementary Table 7. Three out of the nine CEBQ subscales show differences 
between deletion carriers and controls, as well as duplication carriers (Figures 1a–c and Supplementary Table 
8). Deletion carriers show lower level of satiety responsiveness, increased responsiveness to food and higher 
sensitivity to emotional overeating compared with the two other groups. As previously reported in the 
literature,6 BMI z-scores are negatively correlated to the number of genomic copies (Table 1). When BMI z-
score is included in the model, differences in satiety responsiveness between groups are no longer signiﬁcant 
(Supplementary Table 9). None of the other subscales (Enjoyment of Food, Emotional Undereating, Food 
Fussiness, Slowness in Eating, Desire to Drink) showed signiﬁcant difference between groups (Supplementary 
Figure 1 and Supplementary Table 8). 
 
Children who carry a deletion: Relationship between eating behavior, BMI and age 
Age does not affect satiety responsiveness in deletion carriers, whereas BMI z-scores increase progressively 
with age (P= 0.003), as we previously reported14 (Figure 2a). Satiety responsiveness 
does not correlate with BMI z-score in children ⩽ 10 years, but a decrease in the levels of satiety 
responsiveness is signiﬁcantly associated with higher BMI z-score in adolescents 410 years of age (P=0.003; 
Figure 2b). The relationship between the satiety response and BMI z-score in adolescents is not speciﬁc to the 
deletion group and this correlation is also present in controls (P= 0.002). 
 
 
 Similar analyses show that increased scores of food respon-siveness and emotional overeating appear with age 
and do not correlate with BMI z-score in deletion carriers (Supplementary Figure 2). These two measures are 
correlated across all groups (r240.4), and both negatively correlate with satiety responsive-ness in deletion 
carriers (Supplementary Figure 3). 
We further compared deletion carriers with a group of children with an eating disorder deﬁned as loss of 
control over eating. We found no differences between these two groups on the CEBQ subscales 
(Supplementary Table 10 and Supplementary Figure 4). 
Adults: Body perception and eating disorder traits differences between CNV carriers and controls 
Deletion carriers show increased body dissatisfaction and drive for thinness compared with controls and 
duplication carriers (Figures 3a and b and Supplementary Tables 11 and 12). Bulimia score (Figure 3c) and 
externality scale from the Dutch Eating Behavior Questionnaire were comparable between the three groups 
(Supplementary Table 12). When BMI z-score is included in the model, group differences are no longer 
present, suggesting that the above-mentioned effects are mainly related to BMI (Supplementary Table 13). 
To further understand these eating disorder traits in deletion carriers, we compared them with three other 
groups including individuals with OB, BN or BED. Bulimia and Body dissatisfaction scores are similar in deletion 
carriers and the OB group, and both groups score signiﬁcantly lower compared with the BN and BED cohorts 
(Figures 4a and b). Interestingly, deletion carriers show a signiﬁcantly lower drive for thinness compared with 
the three other groups (Figure 4c and Supplementary Tables 14 and 15). 
Subsequently, we investigated whether the speciﬁcity of the relationship between BMI z-score and eating 
disorder differs across groups (deletion carriers, BN, BED and OB). A differential effect of BMI z-score across 
groups is only seen for body dissatisfaction: both eating disorder groups show a positive correlation between 
BMI z-score and body dissatisfaction (BN: r2 = 0.16, P=6.5e − 11; BED: r2 = 0.04, P= 0.01), whereas this 
relationship is not seen neither in OB nor in deletion carriers. 
 
 
 
 
 
 
 
Global cognition, executive functions and BMI 
FSIQ of CNV carriers is about 2 s.d. lower compared with intrafamilial controls (Table 1). We do not ﬁnd 
signiﬁcant relationships between BMI z-score and FSIQ. Analyses of verbal and motor inhibition also show no 
relationship with BMI. There also is no correlation between cognitive scores and eating behavior scales in any 
of the groups. 
Finally, we sought to explore the potential impact of family environment on eating behavior and obesity by 
comparing families where the deletion is de novo or inherited. In the latter case, transmitting parents also 
present cognitive impairments and obesity. The inheritance status was only available in children. Inheritance 
neither affects BMI z-score nor eating behavior. This analysis was not performed in the duplication because of 
the small sample size (de novo = 7; inherited = 24; unknown = 7). 
DISCUSSION 
The present study investigates the relationship between eating behavior and BMI in carriers of a 16p11.2 BP4-
BP5 CNV, who are at risk of obesity or being underweight.12,13 Children who carry a deletion present altered 
satiety responsiveness, which is already present before any diagnosis of obesity. The correlation between 
response to satiety and BMI z-score becomes signiﬁcant in adolescents supporting the notion that satiety 
response in young deletion carriers is associated with future increase in BMI z-score. The relevance of satiety 
responsiveness to obesity has been documented by longitudinal studies showing that appetitive traits in 
infancy are correlated with subsequent weight gain.39,40 Our ﬁndings are also consistent with data on the 
relationship between satiety/satiety responsiveness and genetic factors associated with obesity.24,26,41 
Recent studies in the general population using polygenic risk scores demonstrated that common genetic risk 
for higher BMI also correlates with satiety responsiveness in children even after the exclusion of FTO and 
MC4R, two major genes associated with obesity.25 Along with our results, this suggests that genes that are risk 
factors for obesity might act through appetitive mechanisms. 
Although we interpret our results as a primary effect of satiety, we also show alterations in food 
responsiveness and emotional overeating, two components related to reward sensitivity. A previous study on 
16p11.2 deletion carriers also reported subjective alteration of reward (eating in the absence of hunger and 
sensitivity to boredom or external cues in deletion carriers).27 We recently demonstrated that CNV in the 
16p11.2 region is associated with altered brain structures (orbitofrontal cortex, insula, putamen and thalamus) 
implicated in reward.9 A large body of research has also demonstrated that satiety inﬂuences the subjective 
value of reward.42 Our current inter-pretation of these data is that increased responsiveness to food and 
emotional overeating observed in 16p11.2 deletion carriers may be the consequence of altered satiety 
response. 
Adult deletion carriers do not present with eating disorder as deﬁned in the DSM-5 (BN, BED). Body 
dissatisfaction and bulimia symptoms in deletion carriers are equal to that observed in individuals of the obese 
group and contrast with behaviors observed in the BN and BED groups. Interestingly, deletion carriers present 
with signiﬁcantly lower drive for thinness compared with the obese group with similar BMI. Studies of 
personality traits known to correlate with drive for thinness (e.g. harm avoidance, anxiety) may shed light on 
this difference.43 
Although several studies have demonstrated a correlation between BMI and executive dysfunction in obesity, 
we show no association between BMI z-score and overall cognitive functioning. These results replicate earlier 
reports in 16p11.2 CNV carriers.14 The fact that loss of control over eating children and deletion carriers do 
not differ on any of the behavioral CEBQ dimensions suggests similar underlying mechanisms for their energy 
imbalance. Similarly, we did not ﬁnd any relationship between BMI z-score and inhibition, corroborating 
previous ﬁndings in extreme weight conditions such as anorexia nervosa and obesity.20 This is analogous to 
ﬁndings for the 22q11.2 deletion CNV showing that psychopathology and cognitive deﬁcits are independent 
sequelae.44 
One of the limitations of this work is our reliance on parent- and self-report ratings of eating behavior, which 
are subjective in nature. Possible under- or over-reporting on these measures would have implications for our 
analyses on BMI z-scores. The lack of longitudinal data prevents us from concluding how response to satiety 
evolves over time. Furthermore, the measures of eating behavior varied between the pediatric and adult 
cohorts. However, the study of a high-risk pediatric cohort offers the possibility to explore behavioral 
phenotypes that are not the consequence of long-standing obesity. We observed fewer signiﬁcant effects of 
the duplication on eating behaviors that may be due to smaller sample size of the duplication group. 
To conclude, our ﬁndings provide further insights into the behaviors underlying or associated with energy 
imbalance in 16p11.2 CNV carriers. Altered satiety response is potentially a primary mechanism contributing to 
later obesity in deletion carriers but co-occurring changes in the reward system may also have a role. Study of 
these reciprocal 16p11.2 CNVs and how they affect clinical traits is a powerful tool to shed light on common 
phenotypes such as obesity. For clinicians, a comprehensive characterization of eating behavior will guide care 
of patients presenting with this genetic disorder. 
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